EDIT
Editas Medicine Inc
Clinical-stage biotechnology company focused on CRISPR gene editing therapies
CUSIP: 28106W103HealthcareUS1 holder
Total Value
$41.71M
Total Shares
1.71M
Net Share Change
-426.1K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$41.71M1.71M shares
TRIM-426.1K(-20.0%)